USPTO serial 88237327
HALE & HOLIS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- DELANEY, ZHALEH SYBIL
- Law office
- TMO LAW OFFICE 116 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with HALE & HOLIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Brossard, Quebec, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joseph V. Myers III
Joseph V. Myers III SEYFARTH SHAW LLP1075 PEACHTREE STREET, SUITE 2500ATLANTA, GA 30309UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Cosmetics | ACTIVE | — |
| 005 | Dietary supplements for human consumption; dietary supplements for human consumption featuring natural ingredients; food supplements; food supplements, namely, anti-oxidants; food supplements featuring natural ingredients; food supplements featuring natural ingredients in the nature of fatty acids; nutritional supplements for human consumption; nutritional supplements for human consumption featuring natural ingredients; probiotic supplements; probiotic supplements featuring natural ingredients; mushroom extracts sold as a component ingredient of nutritional supplements and vitamins; nutritional supplements for human consumption in capsule form featuring natural ingredients in the nature of saw palmetto, pygeum, stinging nettle, white deadnettle, common heather and bearberry for relieving benign prostate hyperplasia symptoms; dietary supplement in the form of tablets featuring glucosamine sulphate, chondroitin, chitosan oligosaccharides, methylsulfonylmethane and collagen for use in relieving joint pain and symptoms related to arthritis and osteoarthritis, and for contributing to the formation of healthy cartilage; natural dietary supplements featuring plant extracts in the form of capsules for improving overall health, reducing the frequency of hot flashes, improving the neurovegetative state associated with menopause, improving blood cholesterol levels, alleviating excessive perspiration and enabling regulation of a disrupted sleep cycle; meal replacement bars for weight loss and weight maintenance purposes, namely, meal replacement bars featuring natural ingredients with peanut, crème caramel, fruit, chocolate, apple-cinnamon, coffee, granola and chocolate chip flavors; natural dietary supplements in capsule form for human consumption containing plant extracts for weight loss; vitamin and mineral supplements; vitamin and mineral supplements featuring natural ingredients for human consumption to remedy vitamin and mineral deficiencies; natural dietary supplements featuring plant extracts with calming antioxidant properties; natural dietary supplements featuring plant extracts for improving the immune system, balancing mood swings, and palliating the reduction of estrogen in menopausal women; food supplements, namely, anti-oxidants in tablet form for maintaining good health; natural dietary supplements featuring plant extracts in the form of capsules for soothing respiratory symptoms caused by colds, flu, and bronchitis, and for increasing the bio-availability of vitamin C by decreasing its elimination and oxidation; natural vitamin supplements featuring plant extracts for soothing respiratory symptoms caused by colds, flu, and bronchitis, and for increasing the bio-availability of vitamin C by decreasing its elimination and oxidation; natural dietary supplements featuring plant extracts in the form of infusions and capsules for purifying, diuretic and laxative purposes; natural dietary supplements featuring oligosaccharide chitosan in the form of capsules for use in controlling cholesterol; natural dietary supplements featuring chitosan oligosaccharide in capsule and cream form for use in soothing joint pain and for use as joint anti-inflammatories; vitamin supplements featuring natural ingredients for human consumption in the form of gelatin capsules for use in maintaining an appropriate level of antioxidants in the body to palliate oxidative stress; vitamin supplement for balancing human metabolism, namely, vitamin supplement in tablet form for use in balancing carbohydrate levels and reducing homocysteine levels; mineral supplements in capsule and tablet forms for remedying magnesium deficiencies; dietary supplement featuring natural ingredients for human consumption, namely, dietary supplement in capsule form featuring vitamins, plant extracts and adaptogenic roots for use in increasing stress resistance, stimulating weakened immune systems, and increasing cognitive functions, and for use in decreasing fatigue and hyperglycemia; natural dietary supplements featuring plant and plant root extracts in the form of capsules for use in slowing the advancement of benign prostate hypertrophy, controlling sleep disorders, preventing and treating urinary tract infections, soothing respiratory symptoms stemming from colds or flu, treating moderate Alzheimer's, facilitating digestion of food, and reducing symptoms associated with digestive disorders; natural dietary supplements featuring plant and plant root extracts in the form of capsules for use in treating lumbar pain, arthritis pain, and rheumatic disorders; natural dietary supplements featuring bark extracts, namely, myrobalan, croton, condurango, angostura and croton bark extracts in capsule form for medical and pharmaceutical purposes; natural dietary supplements featuring immuno-stimulant plant extracts in capsule form for soothing respiratory symptoms caused by colds or flu; natural dietary supplements featuring plant leaf and plant root extracts in the form of infusions and capsules for purifying, diuretic and laxative purposes; natural dietary supplements featuring bark extracts, namely, myrobalan, croton, condurango, angostura and croton bark extracts in the form of infusions and capsules for purifying, diuretic and laxative purposes; natural dietary supplements featuring plant leaf and plant flower extracts in the form of capsules for combatting sleep disorders and reducing nervousness; natural dietary supplements featuring bark extracts, namely, myrobalan, croton, condurango, angostura and croton bark extracts in the form of capsules for combatting sleep disorders and reducing nervousness; natural vitamin supplements for human consumption, namely, vitamin supplements in the form of capsules for use in decreasing the duration and severity of cold symptoms, slowing down the development of atherosclerosis, and improving blood circulation and blood pressure; natural food supplements for human consumption, namely, antioxidants featuring fruit extracts in the form of capsules for use in decreasing the duration and severity of cold symptoms, slowing down the development of atherosclerosis, and improving blood circulation and blood pressure; food supplements in the form of gelatin capsules containing soya lecithin and carthane oil to prevent memory disorders and hypercholesterolemia; natural dietary supplements featuring plant extracts for use in preventing hypertension or hypercholesterolemia; vitamin and mineral food supplements in the form of tablets for use in stimulating the appetite and for use in treating acne and furunculosis; vitamin supplements in capsule form featuring fatty acids for use in increasing physical endurance, managing cholesterol levels, and maintaining general good health; natural dietary supplements featuring edible fish oils in gelatin capsule form featuring fatty acids and vitamin E for maintaining prostate health; natural dietary supplements featuring edible fish oils in capsule, gelatin capsule, and liquid form for use in decreasing damage caused by oxidative stress, decreasing the risks of prostate and lung cancer, decreasing the risk of coronary illnesses, treating rheumatoid arthritis, improving muscular strength, endurance, and injury recovery, soothing urological symptoms associated with benign prostate hyperplasia, improving cognitive functions of patients suffering from Alzheimer's or minor memory disorders, reducing fatigue, preventing macular degeneration associated with age, preventing cataracts, maintaining proper retina functioning, maintaining cardiovascular and cognitive health, facilitating brain development and proper functioning, preventing and treating urinary tract infections, decreasing the risks of prostate and lung cancer, reducing the symptoms of light to moderate depression, and improving memory and immune system activity; natural dietary supplements featuring plant extracts and plant root extracts featuring antioxidant properties in capsule, gelatin capsule, and liquid form for use in decreasing damage caused by oxidative stress, decreasing the risks of prostate and lung cancer, decreasing the risk of coronary illnesses, treating rheumatoid arthritis, improving muscular strength, endurance, and injury recovery, soothing urological symptoms associated with benign prostate hyperplasia, improving cognitive functions of patients suffering from Alzheimer's or minor memory disorders, reducing fatigue, preventing macular degeneration associated with age, preventing cataracts, maintaining proper retina functioning, maintaining cardiovascular and cognitive health, facilitating brain development and proper functioning, preventing and treating urinary tract infections, decreasing the risks of prostate and lung cancer, reducing the symptoms of light to moderate depression, and improving memory and immune system activity; natural probiotic supplements in capsule form for human consumption featuring yogurt cultures for regulating intestinal flora and stimulating the immune system; natural food supplements in tablet form for human consumption featuring potassium gluconate for preventing hypokalemia and hypertension; natural dietary supplements in the form of gelatin capsules for human consumption featuring fatty acids for use in preventing eczema, premenstrual syndrome and menopausal symptoms; natural dietary supplements for human consumption, namely, natural dietary supplements in capsule and tablet form featuring chitin composed of crustacean shells, organic beef trachea, chicken sternum extracts and standardized resin extracts for use in soothing osteoarthritis symptoms, reducing joint pain, preventing cartilage deterioration caused by chronic joint disorders, maintaining and building cartilage, reducing arthritis pain, slowing the progression of joint erosion, and reducing the risk of osteoporosis in arthritic patients; natural vitamin and mineral supplements for human consumption, namely, vitamin and mineral supplements in capsule and tablet form for use in soothing menopausal symptoms, reducing premenstrual syndrome symptoms, relaxing muscles, reducing nervous tension, decreasing edema, reducing leg inflammation, decreasing leg pain and tension, maintaining bone mass, preventing osteoporosis, preventing fatigue associated with anemia, and preventing anemia; natural chondroitin preparations for human consumption, namely, chondroitin preparations in capsule form featuring type II collagen and hyaluronic acid for maintaining joint and skin connective tissues; natural dietary supplements for human consumption, namely, dietary supplements in the form of gelatin capsules for use in reducing aging and fatigue; natural products for human use, namely, soluble dietary fiber in the form of capsules to aid in digestion for intestinal regularity; natural dietary supplements featuring plant extracts in the form of capsules and liquids for promoting intestinal regularity, aiding in digestion, and for detoxification and purification; natural mineral supplements for human consumption, namely, mineral supplements in capsule and liquid form for promoting intestinal regularity, aiding in digestion, and for detoxification and purification; natural mineral supplements for human consumption, namely, natural mineral supplements in capsule and tablet form for remedying calcium deficiencies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 30, 2023 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 30, 2023 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 30, 2023 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 7, 2022 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Nov 7, 2022 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Nov 7, 2022 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| May 9, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 9, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 9, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 5, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 5, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 2, 2022 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Apr 18, 2022 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Apr 18, 2022 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Apr 18, 2022 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Oct 13, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 13, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 13, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 1, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 1, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 24, 2021 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Apr 19, 2021 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Apr 19, 2021 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Apr 19, 2021 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Oct 19, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 19, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 19, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 19, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 19, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 15, 2020 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Oct 9, 2020 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Oct 9, 2020 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Oct 9, 2020 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Apr 9, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 9, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 9, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 9, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 9, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 9, 2020 | ALIE | ASSIGNED TO LIE | — |
| Apr 2, 2020 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Apr 2, 2020 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Apr 2, 2020 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Apr 2, 2020 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Nov 14, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 14, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 23, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 23, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 23, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 23, 2019 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Sep 23, 2019 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Sep 23, 2019 | EPEN | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | — |
| Sep 23, 2019 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Sep 20, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 20, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 20, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 22, 2019 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Mar 22, 2019 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Mar 22, 2019 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Mar 15, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 15, 2019 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jan 13, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 24, 2018 | NWAP | NEW APPLICATION ENTERED | — |